RaySearch receives first order for DrugLog
Wednesday, January 15, 2025
STOCKHOLM, Jan. 7, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) today announces that the Polish company Medim has placed an order for the product DrugLog(TM). The order is a result of Medim winning a tender from The Children's Memorial Health Institute in Warsaw, Poland.
DrugLog is RaySearch's cost-effective solution for quickly and efficiently verifying the identity and concentration of compounded injectable medications used, for example, in cancer treatment with with cytostatic drugs (chemotherapy). DrugLog is used to detect errors in the preparation of drugs, which reduces the risk of medication errors. DrugLog is a unique combination of cutting-edge software and reliable well-established hardware for absorption spectroscopy.
The order includes the product DrugLog and support agreements for the second and third year. The Children's Memorial Health Institute is Poland's largest and most well-equipped children's hospital and is directly subordinated to the Polish Ministry of Health. It is also one of the leading teaching hospitals in Poland.
In the beginning of 2024 RaySearch acquired the product DrugLog from Pharmacolog in Uppsala, Sweden, to complement the product offering by improving and/or simplifying quality assurance in cancer treatment with cytostatic drugs.
Medim was founded in 1990 and has extensive experience in selling products and solutions to the healthcare sector in the Polish market.
Mateusz Nejman, Director of New Technologies Department, Medim: "This is an important milestone for our partnership with RaySearch. The new customer is a proof of how our joint efforts and expertise create concrete results in the market."
Johan Löf, founder and CEO, RaySearch: "We are pleased to announce that The Children's Memorial Health Institute in Warsaw, Poland is purchasing DrugLog. Medim is our first customer for DrugLog, which we acquired at the beginning of the year to complement our existing product offering. DrugLog represents a further step towards the vision of providing software support for all types of cancer treatments, including chemotherapy and surgery."
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510?530 00
johan.lof@raysearchlabs.com?
Learn more about us on:
LinkedIn
YouTube
X
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/raysearch-laboratories/r/raysearch-receives-first-order-for-druglog,c4088529
The following files are available for download:
https://mb.cision.com/Main/1102/4088529/3194678.pdf RaySearch Press Release January 7,
2025
https://news.cision.com/raysearch-laboratories/i/press-release-medim,c3366416
Press-release Medim
View original content:https://www.prnewswire.com/news-releases/raysearch-receives-first-order-for-druglog-302344442.html
SOURCE RaySearch Laboratories
|
|
|
|
|
 |
Energy Toolbase Launches Energy Storage Partnership with Sungrow to Support PowerStack 255CS and PowerTitan 2.0 | Jan 22, 2026
|
|
RS now offers Phoenix Contact's pioneering new NearFi technology | Jan 22, 2026
|
|
Quantum Art Raises $100 Million in Series A Round to Drive Scalable, Multi-Core Quantum Computing | Jan 22, 2026
|
|
MetaOptics to Showcase Five Breakthrough Metalens-Powered Products at CES 2026 | Jan 22, 2026
|
|
SCAILIUM Debuts "AI Production Layer" to Overcome GPU Starvation and Slash AI Energy Waste | Jan 22, 2026
|
|
Fresco Raises EUR15m Series C to Power the Future of AI-Driven Cooking and the Connected Kitchen Ecosystem | Jan 22, 2026
|
|
Hesai Recognized as the Only Lidar Company on Morgan Stanley's "Humanoid Tech 25" of Global Robotics Leaders | Jan 22, 2026
|
|
No Assembly Required: Barrett Distribution Centers Powers Maxwood Furniture's West Coast DTC Expansion | Jan 22, 2026
|
|
Einride and IonQ Partnership Uses Quantum Computing to Optimize the Logistics of Electric and Autonomous Freight | Jan 22, 2026
|
|
Lumana Surpasses 50,000 Cameras, Cementing Its Leadership in AI Video Surveillance | Jan 22, 2026
|
|
|
